Han B - Search Results

1

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial.

Han B, Song Y, Li C, Yang W, Ma Q, Jiang Z, Li M, Lian X, Jiao W, Wang L, Shu Q, Wu Z, Zhao Y, Li Q, Gao Q. Han B, et al. Lancet Infect Dis. 2021 Dec;21(12):1645-1653. doi: 10.1016/S1473-3099(21)00319-4. Epub 2021 Jun 28. Lancet Infect Dis. 2021. PMID: 34197764 Free PMC article. Clinical Trial.

2

Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials.

Zeng G, Wu Q, Pan H, Li M, Yang J, Wang L, Wu Z, Jiang D, Deng X, Chu K, Zheng W, Wang L, Lu W, Han B, Zhao Y, Zhu F, Yu H, Yin W. Zeng G, et al. Among authors: han b. Lancet Infect Dis. 2022 Apr;22(4):483-495. doi: 10.1016/S1473-3099(21)00681-2. Epub 2021 Dec 8. Lancet Infect Dis. 2022. PMID: 34890537 Free PMC article. Clinical Trial.

3

[Safety of an inactivated 2019-nCoV vaccine (Vero) in adults aged 60 years and older].

Han BH, Wu ZW, Li MJ, Jin F, Gao Z, Pan LL, Ma JC, Jin H, Zhao YL, Li Q. Han BH, et al. Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Sep 6;56(9):1295-1301. doi: 10.3760/cma.j.cn112150-20220119-00069. Zhonghua Yu Fang Yi Xue Za Zhi. 2022. PMID: 36207894 Clinical Trial. Chinese.

4

Six-month follow-up of a booster dose of CoronaVac in two single-centre phase 2 clinical trials.

Xin Q, Wu Q, Chen X, Han B, Chu K, Song Y, Jin H, Chen P, Lu W, Yang T, Li M, Zhao Y, Pan H, Yu H, Wang L. Xin Q, et al. Among authors: han b. Nat Commun. 2022 Jun 3;13(1):3100. doi: 10.1038/s41467-022-30864-w. Nat Commun. 2022. PMID: 35660738 Free PMC article. Clinical Trial.

5

Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination.

Zhao YL, Han BH, Zhang XJ, Pan LL, Zhou HS, Gao Z, Hao ZY, Wu ZW, Ma TL, Wang F, Li Q, Bi SL, Ma JC. Zhao YL, et al. BMC Infect Dis. 2019 May 30;19(1):482. doi: 10.1186/s12879-019-4134-9. BMC Infect Dis. 2019. PMID: 31146699 Free PMC article.

6

Immune response to different types of hepatitis B vaccine booster doses 2-32 years after the primary immunization schedule and its influencing factors.

Zhao YL, Pan LL, Hao ZY, Jin F, Zhang YH, Li MJ, Zhang XJ, Han BH, Zhou HS, Ma TL, Wang F, Ma JC, Shen LP, Li Q. Zhao YL, et al. Int J Infect Dis. 2020 Apr;93:62-67. doi: 10.1016/j.ijid.2020.01.047. Epub 2020 Jan 28. Int J Infect Dis. 2020. PMID: 32004687 Free article.

7

[The effect of booster dose vaccination 21- to 32-years after primary vaccination with hepatitis B vaccine in the population born from 1986 to 1996 in Zhengding County of Hebei Province].

Zhang XJ, Wu ZW, Zhang YH, Li MJ, Zhou HS, Han BH, Hao ZY, Chu J, Gao Z, Ma JC, Zhao YL. Zhang XJ, et al. Among authors: han bh. Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Sep 6;54(9):942-946. doi: 10.3760/cma.j.cn112150-20200509-00710. Zhonghua Yu Fang Yi Xue Za Zhi. 2020. PMID: 32907282 Chinese.

8

Long-Lasting Virus-Specific T Cell Response with Divergent Features in Self-Resolved and Chronic Hepatitis C Virus Patients 35 Years Postinfection.

Ji W, Zhao M, Zhou J, Zheng H, Li N, Han B, Yin W, Bi S, Gao GF, Zhang Y, Liu WJ. Ji W, et al. Among authors: han b. Immunohorizons. 2022 Mar 7;6(3):191-201. doi: 10.4049/immunohorizons.2200008. Immunohorizons. 2022. PMID: 35256480 Free article.

9

Epidemiological Surveillance of Acute Respiratory Infections Based on Targeted Metagenomic Next Generation Sequencing During the Flu Season after COVID-19 Pandemic in Beijing.

Han B, Li XM, Li R, Ning W, Zhang YY, Tang YF, Zhang Y, Hu L, Li JD, Liu G, Zhang D, Gu L, Xia H, Wang X, Jiang RM. Han B, et al. J Infect. 2024 May 22:106188. doi: 10.1016/j.jinf.2024.106188. Online ahead of print. J Infect. 2024. PMID: 38789013 No abstract available.

10

Prevalence of synthetic phenolic antioxidants in food contact materials from China and their implications for human dietary exposure through take-away food.

Han B, Shang Y, Wang H, Shen Y, Li R, Wang M, Zhuang Z, Wang Z, Fang M, Jing T. Han B, et al. J Hazard Mater. 2024 May 13;473:134599. doi: 10.1016/j.jhazmat.2024.134599. Online ahead of print. J Hazard Mater. 2024. PMID: 38788569

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,356 results

Search Page